Acceder

Publicaciones - FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA

Cargando...
Ortiz-Fernandez P, Iniesta-Navalon C, Urbieta-Sanz E, Gascon-Canovas JJ. Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases. Clin Rheumatol. 2025 Aug;44(8):3389-3390. doi: 10.1007/s10067-025-07559-w. Epub 2025 Jul 4. No abstract available. PubMed PMID: 40613968.
AÑO: 2025; IF: 2.8
40613968
Iniesta-Navalon C, Rios-Saorin M, Anez-Castano R, Rentero-Redondo L, Ortiz-Fernandez P, Marin-Armero Martinez E, Urbieta-Sanz E. Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab. Ther Drug Monit. 2025 Jun 1;47(3):346-352. doi: 10.1097/FTD.0000000000001269. Epub 2024 Nov 15. PubMed PMID: 40341590.
AÑO: 2025; IF: 2.4
40341590
Iniesta-Navalon C, Rios-Saorin M, Rentero-Redondo L, Anez-Castano R, Urbieta-Sanz E. Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patients. Gastroenterol Hepatol. 2025 Jun-Jul;48(6):502277. doi: 10.1016/j.gastrohep.2024.502277. Epub 2024 Oct 21. English, Spanish. PubMed PMID: 39442691.
AÑO: 2025; IF: 1.9
39442691
Anez-Castano R, Iniesta-Navalon C, Almanchel-Rivadeneyra M, Garcia-Villalba E, Oliver-Galera E, Rentero-Redondo L. Therapeutic drug monitoring of inhaled tobramycin in a patient with chronic kidney disease. Eur J Hosp Pharm. 2025 Aug 21;32(5):488-490. doi: 10.1136/ejhpharm-2023-004075. PubMed PMID: 39181698.
AÑO: 2025; IF: 1.5
39181698
Iniesta-Navalon C, Rios-Saorin M, Rentero-Redondo L, Nicolas-de Prado I, Gomez-Espin R, Urbieta-Sanz E. Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease. Rev Esp Enferm Dig. 2025 Apr;117(4):205-212. doi: 10.17235/reed.2024.10521/2024. PubMed PMID: 39629805.
AÑO: 2025; IF: 4.0
39629805
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA